THU133 Inpatient Hypoglycemia Management: Error Rates In Pediatric Diabetes Care

Disclosure: D.A. Odutayo: None. E.M. Rizzi: None. N. Allen: None. Hypoglycemia is a known side effect of exogenous insulin. During severe hypoglycemia, children with diabetes treated with insulin risk neurodevelopmental sequelae as protective glycolysis and ketogenesis are suppressed. Rapid treatmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the Endocrine Society 2023-10, Vol.7 (Supplement_1)
Hauptverfasser: Odutayo, Daniella A, Rizzi, Elise M, Allen, Natalie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Disclosure: D.A. Odutayo: None. E.M. Rizzi: None. N. Allen: None. Hypoglycemia is a known side effect of exogenous insulin. During severe hypoglycemia, children with diabetes treated with insulin risk neurodevelopmental sequelae as protective glycolysis and ketogenesis are suppressed. Rapid treatment of hypoglycemia is crucial to prevent deleterious effects on neurocognition. There is a paucity of data elucidating inpatient hypoglycemia incidence and adherence to treatment standards in hospital care. The goal of this study is to assess the rate of hypoglycemia in children and adolescents with diabetes in the inpatient setting, and to assess adherence to American Diabetes Association (ADA) standards of care in treatment of hypoglycemia. Hypoglycemia is defined as blood glucose ≤ 70 mg/dL in children ≥5 years old, and ≤ 80 mg/dL in children
ISSN:2472-1972
2472-1972
DOI:10.1210/jendso/bvad114.1385